-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Vijaya Raj Bhatt, MBBS, MS1*, Christopher Wichman, PhD2*, Zaid S. Al-Kadhimi, MD3*, Thuy T. Koll, MD4*, Alfred L Fisher2*, Ann Berger5*, James O. Armitage, MD6, Sarah A. Holstein, MD, PhD7, Lori Maness, MD3 and Krishna Gundabolu, MBBS3

1The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
2University of Nebraska Medical Center, Omaha
3Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
4Division of Geriatrics, University of Nebraska Medical Center, Omaha, NE
5University of Nebraska Medical Center, Omaha, NE
6Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE
7Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE

Adriano Venditti, MD1, Jing-Zhou Hou, MD, PhD2, Pierre Fenaux3, Brian A. Jonas, MD, PhD4, Radovan Vrhovac, MD, PhD5*, Pau Montesinos, MD, PhD6*, Jacqueline S. Garcia, MD7, David Rizzieri, MD8*, Michael J. Thirman, MD9, Melissa Montez, PharmD10*, Yingyi Liu11*, John Katsetos, PA-C11*, Jalaja Potluri, MD11, Catherine Miller, PharmD11* and Vinod A. Pullarkat, MD12*

1Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
2Hematology and BMT, Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
3Hôpital St. Louis /Assistance Publique- Hôpitaux de Paris and Université de Paris, Paris, France
4Division of Cellular Therapy, Bone Marrow Transplant, and Malignant Hematology, Department of Medicine, University of California Davis School of Medicine, Sacramento, CA
5University of Zagreb School of Medicine, Zagreb, Croatia
6Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Novant Health Cancer Institute, Winston Salem, NC
9Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
10Genentech, South San Francisco, CA
11AbbVie Inc., North Chicago, IL
12Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

Pierre-Yves Dumas, MD, PhD1*, Emmanuel Raffoux2*, Emilie Berard, MD3*, Sarah Bertoli4*, Marie Anne Hospital, MD5*, Mael Heiblig, MD, PhD6*, Yohan Desbrosses, MD7*, Caroline Bonmati, MD8*, Cecile Pautas, MD9*, Juliette Lambert, MD, PhD10*, Corentin Orvain, MD, PhD11*, Anne Banos, MD12*, Florence Pasquier, MD, PhD13*, Pierre Peterlin, MD14*, Tony Marchand, MD, PhD15*, Madalina Uzunov, MD16*, Jamilé Frayfer, MD17*, Pascal Turlure, MD18*, Thomas Cluzeau, MD, PhD19, Eric Jourdan, MD20*, Chantal Himberlin21*, Emmanuelle Tavernier, MD22*, Alban Villate, MD23*, Stéphanie Haiat24*, Marie-Lorraine Chretien, MD25*, Martin Carre, MD26*, Sylvain Chantepie, MD27*, Iona Vaida, MD28*, Mathieu Wemeau, MD29*, Safia Chebrek30*, Gaëlle Guillerm, MD31*, Romain Guieze, MD, PhD32*, Houria Debarri33*, Eve Gehlkopf, MD34*, Kamel Laribi, MD35*, Ambroise Marçais, MD, PhD36*, Alberto Santagostino37*, Marie C Bene, PharmD, DPhil38*, Ariane C Mineur, CRA39*, Arnaud Pigneux40*, Herve Dombret, MD PhD41 and Christian Recher, MD42

1Department of Clinical Hematology, Bordeaux University Hospital, PESSAC, France
2Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
3Service d'Epidémiologie, CHU de Toulouse, Toulouse, France
4Institut Universitaire du Cnacer de Toulouse, Toulouse, FRA
5Onco-Hematology Department, Paoli-Calmette Cancer Institute, Marseille, France
6Centre Hospitalier Lyon Sud / Service d'Hématologie, Hospices Civils de Lyon, Pierre Bénite, France
7Besancon University Hospital, Besancon, France
8Service D'Hématologie, Centre Hospitalier Universitaire De Nancy, Nancy, FRA
9Hematology Department, Henri Mondor University Hospital, CRETEIL, France
10Service d'Hématologie et Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France
11Angers University Hospital, Angers, France
12Service d'Hematologie, Centre Hospitalier De Bayonne, Bayonne, FRA
13Gustave Roussy, Département clinique d'hématologie, INSERM UMR1170, Villejuif, FRA
14Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
15Rennes University Hospital, Rennes, France
16Hopital Pitié-Salpetriere, Paris, France
17Hématologie, Meaux Hospital, Meaux, France
18Department of Clinical Hematology, Limoges University Hospital, Limoges, France
19Département d'Hématologie Clinique, Université Côte d'Azur, CHU Nice, Nice, Provence Alpes Cote d'Azur, France
20CHU Nimes, Nimes, FRA
21HOPITAL, REIMS, France
22Hematology Department, Oncology institute of Loire, Saint Priest en Jarez, France
23Service d'hématologie et thérapie cellulaire, Hôpital Bretonneau, CHRU de Tours, Tours, France
24CH Sud Francilien, Hematology, Corbeil Essonnes, France
25CHU Dijon, DIJON, FRA
26Hematology, CHU Grenoble Alpes, La Tronche, France
27Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen Cedex 9, France
28Hematology Department, Pontoise Hospital, Pontoise, France
29CHR de Roubaix, Roubaix, FRA
30service d’onco-hématologie, CH Avignon, Avignon, FRA
31Department of Hematology, Brest University Hospital, Brest, France
32Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
33CH, Metz, FRA
34Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
35Hématologie clinique, CH Le Mans, Le Mans, France
36Hematology Department, Necker University Hospital, PARIS, France
37Hematology, CH de Troyes, Troyes, France
38Hematology Biology, Nantes University Hospital, Nantes, France
39FILO study group, Bordeaux, France
40Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
41Hopital Saint-Louis, Assistance Publique - Hopitaux De Paris (AP-HP), Paris, FRA
42Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Anna B. Halpern, MD1,2, Eduardo P Rodríguez-Arbolí, MD2,3*, Megan Othus, PhD4,5, Kelsey-Leigh A Garcia, BA6*, Mary-Elizabeth M. Percival, MD1,7, Ryan D. Cassaday, MD8, Vivian Oehler, MD2,9, Pamela S. Becker, MD, PhD1,10,11, Jacob S. Appelbaum, MD, PhD2,12, Janis L. Abkowitz, MD2, Johnnie J. Orozco, MD, PhD2,13, Sioban B. Keel, MD2,14, Paul C. Hendrie, MD, PhD1,2, Bart L. Scott, MD15,16, Cristina Ghiuzeli, MD1,2, Roland B. Walter, MD, PhD, MS2,17,18 and Elihu H. Estey, M.D.2,14

1Department of Medicine, University of Washington, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
3Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville, Spain
4Department of Biostatistics, University of Washington School of Public Health, Seattle, WA
5Division of Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA
6University of Washington, Seattle, WA
7Fred Hutchinson Cancer Center, Seattle, WA
8UW/FHCRC, Seattle, WA
9Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
10Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
11University of Washington Inst. for Stem Cell and Regenerative Med., Irvine, CA
12Department of Medicine, Division of Hematology, Seattle, WA
13Department of Medicine/Division of Medical Oncology, University of Washington, Seattle, WA
14Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
15Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
16Fred Hutchinson Cancer Research Center, Seattle, WA
17Division of Hematology, Dept of Medicine, University of Washington Medical Center, Seattle, WA
18Department of Epidemiology, University of Washington Medical Center, Seattle, WA

Chezi Ganzel1,2*, Yakir Moshe, MD, PhD3,4,5,6*, Itai Levi7,8*, Boaz Nachmias, MD, PhD9*, Sigal Tavor, MD10*, Jonathan Canaani, MD11,12, Tsila Zuckerman, MD13,14, Doaa Okasha, MD15*, Ilana Hellmann, MD16*, Tamar Tadmor, MD14,17*, Najib Dally, MD18,19*, Galia Stemer, MD20,21*, Raanan Cohen, MD22*, Jenia Berelovich, MSc23*, Noa Rivlin23*, Neta Frankel, PhD23*, Moshe Grunspan23*, Keren Ofek, PhD23*, Yishai Ofran, MD24,25 and Ofir Wolach, MD11,26,27*

1Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
2Shaare Zedek Medical Center, Jerusalem, Israel
3The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
5BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
6Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
7Institute of Hematology, Soroka University Medical Center, Faculty of Health Sciences, Beersheba, Israel
8Soroka University Medical Center, Be'er-Sheva, Israel
9Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
10Hemato-Oncology, Assuta Medical Center, Tel Aviv, Israel
11Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
12Hematology Division, Sheba Medical Center, Givatayim, Central, Israel
13Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
14The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
15Hematology Unit,, Ha’Emek Medical Center, Afula, Israel
16Meir Medical Center, Kfar Saba, Israel
17Bnai Zion Medical Center, Haifa, Israel
18Azrieli faculty of Medicine, Bar Ilan University, Safed, Israel
19Ziv Medical Center, Institute of hematology and blood bank, Safed, Israel
20Hematology Institute, Galilee Medical Center, Nahariya, Israel
21Bar Ilan faculty of Medicine, Zefat, Israel
22AbbVie Inc, Hod-Hasharon, Israel
23AbbVie Inc., Hod-Hasharon, Israel
24Department of Hematology, Shaarei Zedek Medical Center, Jerusalem, Israel
25Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
26Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Petah –Tikva, Israel
27Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel

Alexandre Bazinet, MD1, Hagop Kantarjian, MD2, Gautam Borthakur, MD1, Musa Yilmaz, MD3, Prithviraj Bose, MD4, Elias Jabbour, MD1, Yesid Alvarado, MD1, Kelly S. Chien, MD1, Naveen Pemmaraju, MD1, Koichi Takahashi, MD, PhD5, Nicholas Short, MD5, Naval Daver, MD1, Ghayas C. Issa, MD1, Nitin Jain, MD3, Debra Bull Linderman, RN6*, Courtney D. DiNardo, MD, MSCE1, Jan A. Burger, MD, PhD1, Alessandra Ferrajoli5, Guillermo Montalban-Bravo, MD1, Guillermo Garcia-Manero, MD5, Koji Sasaki, MD1, Farhad Ravandi, MD1 and Tapan M. Kadia, MD3

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX

Matteo Piccini1*, Sofia Pilerci, MD2*, Barbara Scappini, MD3*, Francesco Mannelli, MD4*, Gaia Ciolli, MD5*, Andrea Pasquini, MD5*, Laura Fasano, MD5*, Elisa Quinti, MD5*, Paola Guglielmelli, MD, PhD6, Carmela Mannarelli, PhD7*, Fabiana Pancani, PhD7,8*, Michela Zizza8*, Leonardo Signori, PhD8*, Alessandro M. Vannucchi9 and Giacomo Gianfaldoni, MD2*

1SOD Ematologia, SOD Ematologia, Università Di Firenze, AOU Careggi, Firenze, Italy, Firenze, Italy
2SOD Ematologia, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
3SOD Ematologia, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
4SOD Ematologia, CRIMM (Center Research and Innovation of Myeloproliferative Neoplasms), Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
5SOD Ematologia, Scuola di Specializzazione in Ematologia, Azienda Ospedaliera Universitaria Careggi, Università degli Studi di Firenze, Firenze, Italy
6CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
7University of Florence, AOU Careggi, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Italy, Florence, Italy
8CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
9CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera–Universitaria Careggi, Università degli Studi di Firenze - Azienda Ospedaliera Universitaria Careggi, Florence, Italy

Mark G. Faber, DO1, Jeffrey Baron, PharmD2, Han Yu, PhD3*, Hassan Awada, MD4, Tara L. Cronin, BA5*, James E. Thompson, MD5, Amanda Przespolewski, DO6, Steven D. Green, MD6*, Pamela J. Sung, MD5, Elizabeth A. Griffiths, MD1 and Eunice S. Wang, MD5

1Department of Medicine, Leukemia Service, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Akron, OH
5Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Department of Medicine, Leukemia Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Agnieszka Wierzbowska, MD, PhD1, Anna Czyz, MD, PhD2*, Agnieszka Pluta, MD, PhD1*, Marta Antonina Libura, MD, PhD3*, Sebastian Giebel, MD, PhD4*, Piotr Stelmach, MD, PhD5*, Magdalena Czemerska1*, Kinga Krawiec, MD6*, Anna Kopinska, MD, PhD7*, Krzysztof Wozniczka, MD, PhD8*, Grzegorz Helbig, MD, PhD8*, Janusz Halka, MD, PhD9*, Marta Anna Sobas, MD, PhD2*, Tomasz Wróbel2, Andrzej Szczepaniak, MD, PhD10*, Lidia Gil, MD, PhD11, Magdalena Dutka, MD, PhD12*, Maria Bieniaszewska, MD, PhD12*, Tomasz Gromek, MD, PhD13*, Marek Hus, MD, PhD14*, Elzbieta Patkowska, MD, PhD15*, Marzena Watek, MD PhD15*, Ewa Lech-Marańda, MD, PhD16*, Agnieszka Kopacz, MD, PhD17*, Katarzyna Dulik, MD4*, Jerzy Holowiecki, MD, PhD4*, Agata Obara, MD18*, Edyta Cichocka, MD19*, Krzysztof Gawronski20*, Monika Mordak-Domagala, MD21*, Ameenah Sukkur22*, Andi Rustani23*, Pinkal Desai, MD, MPH24, Michael Samuel, MD22*, Nuria Mencia Trinchant, PhD22*, Sangmin Lee22, Justin D. Kaner, MD25, Ellen Ritchie, MD22, Monica L. Guzman, PhD26 and Gail J. Roboz, MD22

1Department of Hematology Medical University of Lodz, Provincial Multi-specialist Oncology and Traumatology Center, Lodz, Poland
2Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
3Department of Hematology, Transplantology and Internal Diseases, Warsaw Medical University, Warsaw, Poland
4Department of Hematology and Bone Marrow Transplantation, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland
5Provincial Multi-specialist Oncology and Traumatology Center Lodz, Poland, Lodz, Poland
6Department of Hematology, Medical University of Lodz, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
7Medical University of Silesia, Katowice, Poland
8Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
9Department of Hematology, Warmian-Masurian Cancer Center of The Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland
10Department of Hematology and Bone Marrow Transplantation, Medical University, Poznan, Poland
11Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
12Department of Hematology, Medical University of Gdansk, Gdansk, Poland
13Department of Hematooncology and Bone Marrow Transplantation, Medical University, Lublin, Poland
14Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
15Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
16Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
17Department of Hematology, Medical University of Rzeszow, Rzeszow, Poland
18Department of Hematology, Holly Cross Oncology Center, Kielce, Poland
19Department of Hematology and Bone Marrow Transplantation, Copernicus Memorial Hospital, Torun, Poland
20Department of Hematology, Military Medical Institute, Warsaw, Poland
21Lower Silesian Center for Cellular Transplantation and National Bone Marrow Donor Registry, Wroclaw, Poland
22Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY
23Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York
24Weill Cornell Medical College, New York, NY
25Department of Medicine, Division of Hematology and Medical Oncology, Leukemia Program, Weill-Cornell Medicine, Syosset, NY
26Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

Henry Wood, MBBS1, Christianne Bourlon1*, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP2, Albert Borg3*, Jiri Pavlu4*, Patrick Elder5*, David C Taussig, PhD, FRCPath, MRCP6, Scott Veitch7*, Steven Knapper8, Jad Othman, MBBS7, Richard Dillon, MA PhD MRCP FRCPath7, James Aries9*, Emily Mitchell10*, Faisal Basheer10*, Steven Leak11*, Vidhya Murthy12*, Joe W Cross13*, Priyanka Mehta13*, Manish Jain14*, Anjum Khan14*, Ho Lam15*, Sarah Leong, MD15*, Jenny O'Nions15*, Charles Craddock12, Victoria Potter16*, Mhairi Copland, PhD, MBBChir, FRCP, FRCPath17 and Pramila Krishnamurthy, MD1*

1King's College Hospital NHS Foundation Trust, London, United Kingdom
2King's College Hospital NHS, London, United Kingdom
3Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
4Centre for Haematology, Imperial College Healthcare NHS trust, London, United Kingdom
5The Royal Marsden NHS Foundation Trust, London, United Kingdom
6The Royal Marsden NHS Foundation Trust, New Malden, United Kingdom
7Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
8Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom
9Bart's Health NHS Trust, London, United Kingdom
10Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
11Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, United Kingdom
12Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
13University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
14St James's Institute of Oncology, The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
15University College London Hospitals NHS Foundation Trust, London, United Kingdom
16BSBMTCT, King's College Hospital NHS Foundation Trust, London, United Kingdom
17Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

Ahmad Ghorab, MD, MSc1, Mark R. Litzow, MD2, Naseema Gangat, M.B.B.S2*, Aref Al-Kali, MD2, Mithun V. Shah, MD, PhD2, Hemant S. Murthy, MD1, Ayalew Tefferi, MD2, Hassan B. Alkhateeb, MD2*, Kebede Begna, MD3, Mrinal M. M. Patnaik, MD2, James M. Foran, MD1 and Talha Badar, MD4

1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
2Division of Hematology, Mayo Clinic, Rochester, MN
3Divison of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL

Helena Pomares, PhD1*, Villarreal Hernandez Jasson, MD1*, Susana Vives, PhD2*, Marta Cervera, MD3*, Rosa Coll, MD4*, Lurdes Zamora, PhD2*, Clara Maluquer, MD1*, Gladys Ibarra, MD2*, Julia Ribes Amoros1*, Georgina Gener-Ricós, MD5*, Mercedes Galiano1*, Anna Sureda6 and Montserrat Arnan Sangerman, PhD1*

1Hematology Department. Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, L'Hospitalet de Llobregat. Barcelona, Spain
2Hematology Department. Institut Català d’Oncologia, Hospital Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras. Universitat Autònoma de Barcelona, Badalona. Barcelona, Spain
3Hematology Department. Institut Català d'Oncologia. Hospital Universitari Joan XXIII, Tarragona, Spain
4Hematology Department. Institut Català d’Oncologia. Hospital Doctor Josep Trueta. Institut d'Investigació Biomèdica de Girona (IDIBGI), Universitat de Girona, Girona, Spain
5Hematology Department. Institut Català d’Oncologia, Hospital Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras. Universitat Autònoma de Barcelona, Badalona. Barcelona, ESP
6Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain

Stephanie Boisclair, MD, Edward Zhou, MD*, Phyu Thin Naing, MBBS, David Chitty, DO* and Jonathan E. Kolitz, MD

Monter Cancer Center, Northwell Health Cancer Institute - Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY

Hanan Alharthy, MBBS1, Fahad Alkaabba, MBBS2*, Matthew Williams, MD2*, Elizabeth Corley, MD3,4*, Kathryn A. F. Kline, MD, MPH1, Jennie Y. Law, MD1, Seung Tae Lee, MD, PhD1, Sandrine Niyongere, MD1, Vu H. Duong, MD, MS1, Maria R. Baer, MD1 and Moaath K. Mustafa Ali, MD, MPH1,5

1University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
2Department of Medicine, University of Maryland Medical Center, Baltimore, MD
3University of Maryland School of Medicine, Baltimore, MD
4Weil-Cornell Medical Center, New York, NY
5Leukemia Division, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH

Lydia D Chow, MD1, Denaly Chen, MD1, Maria E. Vergara-Lluri, MD2, Eric Tam, MD1, Karrune Woan, MD, PhD1, Preet M. Chaudhary, MD, PhD1, George Yaghmour, MD1 and Abdullah Ladha, MD, MPH1

1Division of Hematology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
2Dept. of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA

Faustine Ong, MD1*, Nicholas Short, MD2, Naval Daver, MD3, Tapan M. Kadia, MD3, Courtney D. DiNardo, MD, MSCE3, Musa Yilmaz, MD4, Yesid Alvarado, MD3, Kenneth Vaughan, RN3*, Sherry A. Pierce, BSN, BA3*, Hagop Kantarjian, MD5, Guillermo Garcia-Manero, MD6 and Farhad Ravandi, MD7

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, CA
2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
7Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Ashley Sidebottom1*, Hannah Otiker, PharmD1*, Purnima Sravanti Teegavarapu, MD2, Gustavo Rivero, MD2 and Grace Hwang, PharmD1*

1Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
2Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX

Chiara Sartor, MD, PhD1*, Lorenzo Brunetti, MD, PhD2*, Ernesta Audisio3*, Alessandro Cignetti, MD, PhD4, Letizia Zannoni, MD5*, Gianluca Cristiano, MD5*, Jacopo Nanni, MD5*, Emanuela Ottaviani, M.Sc.6*, Lorenza Bandini, M.Sc.6*, Sarah Parisi, MD, PhD6, Stefania Paolini, MD, PhD6*, Sofia Sciabolacci, MD, PhD7*, Valeria Cardinali, MD8*, Cristina Papayannidis, MD, PhD9, Michele Cavo, MD10,11*, Maria Paola Martelli, MD, PhD12 and Antonio Curti, MD, PhD13

1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
2University Hospital of Ancona, Ancona, Italy
3TORINO CITTÀ DELLA SALUTE E DELLA SCIENZA, Torino, Italy
4Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
5Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
6IRCCS Azienda ospedaliero-universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
7Institute of Hematology, Centro Ricerche Emato-Oncologiche, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy
8University of Perugia, Perugia, Italy
9IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
10Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
11Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “ L. and A. Seràgnoli”,, University of Bologna, Bologna, Italy
12University and Hospital of Perugia, Perugia, Perugia, Jamaica
13IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy

Yasmin Abaza, MD, Talha Khan*, Shira Dinner, MD, Olga Frankfurt, MD* and Jessica K. Altman, MD

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Jorge M. Ramos Perez, MD1, Jose Tinajero2*, Dat Ngo, PharmD2*, Jianying Zhang, PhD3,4*, Paul B. Koller, MD1, Vaibhav Agrawal, MD1, Hoda Pourhassan, MD1*, Monzr M. AL Malki, MD1, Amandeep Salhotra, MD5, Haris Ali, MD1, Ahmed Aribi, MD1*, Karamjeet S. Sandhu, MD1, Shukaib Arslan, MD1*, Salman Otoukesh, MD1*, Idoroenyi Amanam, MD1, Andrew S. Artz, MD, MS1, Pamela S. Becker, MD, PhD1, Forrest M. Stewart, MD1*, Eileen P. Smith, MD1, Peter Curtin, MD1*, Stephen J Forman, MD1, Ryotaro Nakamura, MD1*, Vinod A. Pullarkat, MD1*, Guido Marcucci, MD1, Anthony S. Stein, MD1*, Ibrahim Aldoss, MD1 and Brian J Ball, MD1

1City of Hope National Medical Center, Duarte, CA
2Department of Pharmacy, City of Hope National Medical Center, Duarte, CA
3Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
4Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA
5City of Hope Medical Center, Duarte, CA

*signifies non-member of ASH